Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Geron Corp
(NQ:
GERN
)
4.490
-0.180 (-3.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geron Corp
< Previous
1
2
3
4
5
Next >
Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
May 02, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
April 01, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
March 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
March 29, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 21, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Presentations at American Society of Hematology Annual Meeting
December 14, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Appointment of Chief Business Officer
December 02, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Geron Corporation
Via
Business Wire
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
November 12, 2021
From
Geron Corporation
Via
Business Wire
Geron Presents Investor Event Highlights
November 09, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
November 04, 2021
From
Geron Corporation
Via
Business Wire
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
October 25, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 18, 2021
From
Geron Corporation
Via
Business Wire
Geron to Host a Virtual Investor Event in November
October 15, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
October 11, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 16, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces September Investor Conference Presentation Webcasts
September 01, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 19, 2021
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
August 16, 2021
From
Geron Corporation
Via
Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
August 13, 2021
Via
FinancialNewsMedia
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
August 05, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 22, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
June 17, 2021
From
Geron Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.